Skip to main content
Top
Published in: Trials 1/2022

Open Access 01-12-2022 | Diseases of the neuromuscular synapses and muscles | Correction

Correction: Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy

Authors: Alaa Abouhajar, Lisa Alcock, Theophile Bigirumurame, Penny Bradley, Laura Brown, Ian Campbell, Silvia Del Din, Julie Faitg, Gavin Falkous, Grainne S. Gorman, Rachel Lakey, Robert McFarland, Jane Newman, Lynn Rochester, Vicky Ryan, Hesther Smith, Alison Steel, Renae J. Stefanetti, Huizhong Su, Robert W. Taylor, Naomi J. P. Thomas, Helen Tuppen, Amy E. Vincent, Charlotte Warren, Gillian Watson, The AIMM Trial Group:

Published in: Trials | Issue 1/2022

Login to get access

Excerpt

Correction: Trials 23, 789 (2022)
Metadata
Title
Correction: Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy
Authors
Alaa Abouhajar
Lisa Alcock
Theophile Bigirumurame
Penny Bradley
Laura Brown
Ian Campbell
Silvia Del Din
Julie Faitg
Gavin Falkous
Grainne S. Gorman
Rachel Lakey
Robert McFarland
Jane Newman
Lynn Rochester
Vicky Ryan
Hesther Smith
Alison Steel
Renae J. Stefanetti
Huizhong Su
Robert W. Taylor
Naomi J. P. Thomas
Helen Tuppen
Amy E. Vincent
Charlotte Warren
Gillian Watson
The AIMM Trial Group:
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Trials / Issue 1/2022
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-022-06814-8

Other articles of this Issue 1/2022

Trials 1/2022 Go to the issue